These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31923631)

  • 21. Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
    Xu W; Chen G; Zhu W; Zuo Z
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6203-7. PubMed ID: 20850315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis and Evaluation of 2,4,6-substituted Pyrimidine Derivatives as BACE-1 Inhibitor: Plausible Lead for Alzheimer's Disease.
    Jain P; Wadhwa PK; Jadhav HR
    Med Chem; 2021; 17(10):1194-1206. PubMed ID: 33349218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural bioinformatics-based identification of EGFR inhibitor gefitinib as a putative lead compound for BACE.
    Niu M; Hu J; Wu S; Xiaoe Z; Xu H; Zhang Y; Zhang J; Yang Y
    Chem Biol Drug Des; 2014 Jan; 83(1):81-8. PubMed ID: 24516878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of statine-containing BACE inhibitors.
    Hu J; Cwi CL; Smiley DL; Timm D; Erickson JA; McGee JE; Yang HC; Mendel D; May PC; Shapiro M; McCarthy JR
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4335-9. PubMed ID: 14643321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.
    Ng RA; Sun M; Bowers S; Hom RK; Probst GD; John V; Fang LY; Maillard M; Gailunas A; Brogley L; Neitz RJ; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Adler M; Yao N; Zmolek W; Nakamura D; Quinn KP; Sauer JM; Bova MP; Ruslim L; Artis DR; Yednock TA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4674-9. PubMed ID: 23856050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress toward the discovery and development of efficacious BACE inhibitors.
    Durham TB; Shepherd TA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides.
    Eom TK; Ryu B; Lee JK; Byun HG; Park SJ; Kim SK
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):214-7. PubMed ID: 22424182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.
    Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW
    Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease.
    Kumar A; Srivastava G; Sharma A
    Comput Biol Chem; 2017 Dec; 71():1-9. PubMed ID: 28950235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.
    Rueeger H; Rondeau JM; McCarthy C; Möbitz H; Tintelnot-Blomley M; Neumann U; Desrayaud S
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1942-7. PubMed ID: 21388807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.
    Thompson LA; Shi J; Decicco CP; Tebben AJ; Olson RE; Boy KM; Guernon JM; Good AC; Liauw A; Zheng C; Copeland RA; Combs AP; Trainor GL; Camac DM; Muckelbauer JK; Lentz KA; Grace JE; Burton CR; Toyn JH; Barten DM; Marcinkeviciene J; Meredith JE; Albright CF; Macor JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6909-15. PubMed ID: 21974952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-silico Studies and Biological Activity of Potential BACE-1 Inhibitors.
    Arya R; Paliwal S; Gupta SP; Sharma S; Madan K; Mishra A; Verma K; Chauhan N
    Comb Chem High Throughput Screen; 2021; 24(5):729-736. PubMed ID: 32957879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2910-2913. PubMed ID: 30017317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and discovery of C2-fluoroalkyl iminothiazine dioxides as BACE inhibitors.
    Taoka BM; Wu WL; Hao J; Dolmaski M; Wang H; Levorse D; Orth P; Hyde LA; Smith B; Michener MS; Kennedy ME; Parker EM; Cumming JN
    Bioorg Med Chem Lett; 2022 Jan; 56():128463. PubMed ID: 34838652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of pharmacophore model, synthesis and biological evaluation of N-phenyl-1-arylamide and N-phenylbenzenesulfonamide derivatives as BACE 1 inhibitors.
    Huang W; Yu H; Sheng R; Li J; Hu Y
    Bioorg Med Chem; 2008 Dec; 16(24):10190-7. PubMed ID: 19013073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation.
    Stauffer SR; Stanton MG; Gregro AR; Steinbeiser MA; Shaffer JR; Nantermet PG; Barrow JC; Rittle KE; Collusi D; Espeseth AS; Lai MT; Pietrak BL; Holloway MK; McGaughey GB; Munshi SK; Hochman JH; Simon AJ; Selnick HG; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1788-92. PubMed ID: 17257835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.